Category: Radiology Updates

FDA approves first PSMA PET imaging agent for prostate cancer

US FDA approves the Piflufolastat F-18 injection for prostate cancer detection It is the first fluorinated prostate-specific membrane antigen (PSMA) agent approved by the FDA commercially available PSMA PET imaging agent. It allows doctors to see suspected prostate cancer at an early stage.

This is a highly effective imaging approach to detect the spread of cancer to other parts of the body.

Read the full article:

Korea makes medical imaging smarter with big data & deep learning

A research team from the Korean Ministry of Science has developed a technology that improves both the speed and accuracy of disease diagnosis. They applied big data deep learning technology that has been used to diagnose the reliability of mechanical parts and equipment to ultrasound imaging equipment to develop diagnostic imaging assistance technology using machine learning.

The research team plans to modify the deep learning model to improve the accuracy of aortic plaque analysis. This technology achieves a diagnosis with an accuracy of 80%.

Read the full article :